YC S21
Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
About
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Founders
- Marian Kupculak
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Sensible Biotechnologies.
See family office activityIndustry & Focus
HealthcareTherapeuticsSynthetic BiologyBiotechManufacturingBiotechnology